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Thymus-independent (TI)1 antigens provide powerful tools to elucidate the require- 
ments for specific antigen-induced triggering of B lymphocytes. Recently it has been 
proposed that TI antigens can be divided into two groups  (1,  2).  TI antigens that 
stimulate  substantial  responses  by  B  cells  from  both  immunologically defective 
CBA/N mice and normal neonatal mice, such as trinitrophenylated Brucella abortus 
(TNP-BA),  are designated as TI-1  antigens (1-3).  In contrast, TI-2 antigens evoke 
antibody responses only by B cells from normal adult mice but not by B cells from 
adult CBA/N or normal neonatal mice. Examples of TI-2 antigens are trinitrophenyl 
aminoethylcarbamyl-methyl  Ficoll (TNP-FicolI),  polyinosinic-polycytidilic  acid, dex- 
tran  and  pneumococcal  polysaccharides  (4-7).  This  classification  of TI  antigens 
correlates well with the observations that B lymphocytes from neonatal mice and from 
the immunodeficient CBA/N mice show  certain common surface phenotypic and 
functional characteristics. These properties distinguish such B cells from one subset of 
B cells found in the spleens of normal adult mice (8-11). The presence of at least two 
phenotypically distinct subpopulations of murine B cells raises the possibility that the 
differential stimulatory capacity of TI-1 and TI-2 antigens is due to differences in the 
triggering requirements of B-cell subpopulations (1, 12). According to this view, TI-2 
antigens activate only that subset  of B lymphocytes which is unique to adult mice 
while TI-1  antigens stimulate either only the early developing (CBA/N like) B cells 
or both early and late-appearing subsets of B lymphocytes. 
We have recently prepared an alloantiserum (anti-Lyb 5.1) which is cytotoxic for 
60% of B lymphocytes from adult mice and therefore divides B cells into Lyb5  ÷ and 
Lyb5- subpopulations (13). In the course  of analyzing the functional properties of 
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Lyb5  ÷ and Lyb5- subpopulations of normal adult B  lymphocytes, we have observed 
that  anti-Lyb 5.1  serum,  if present in the culture continuously, inhibits the in vitro 
anti-TNP  antibody  response  to  the  TI-2  antigens  such  as  TNP-Ficoll  and  TNP- 
dextran.  This  serum  does  not  inhibit  the  in  vitro  anti-TNP  antibody  response  to 
optimal concentrations of the TI-1  antigens, TNP-BA and TNP-lipopolysaccharide. 
The  ability of anti-Lyb  5.1  serum  to  inhibit  antibody  responses  to  TI-2  antigens 
suggests that it recognizes a cell surface determinant(s) which plays an important role 
in the activation of B  cells by TI-2 antigens. However, the blocking activity of anti- 
Lyb  5.1  serum  appears  to be distinct  from  the cytotoxic activity of this antiserum, 
since the cells of AL/N  mice are sensitive to the cytotoxic activity but resistant to the 
blocking activity. Furthermore, data to be presented in a subsequent paper will show 
that the gene(s) specifying Lyb 5.1  segregate independently from the gene(s) respon- 
sible for the alloantigen involved in the in vitro blocking of TI-2 antibody responses.  2 
Materials and  Methods 
Animals.  DBA/2N, C57BL/6N, AL/N, C3H/HeN, BALB/cAnN, B10.D2/nSnN,  (CBA/N 
×  DBA/2N)F1, and  (DBA/2N  x  CBA/N)F1  mice were obtained from the  Small Animal 
Section, Division of Research Services, National Institutes of Health. The immune defect of 
CBA/N mice is X-linked; FI male mice of a cross between CBA/N females and DBA/2 males 
[(CBA/N  ×  DBA/2)FI males]  are hemizygous for the defective gene  and  are functionally 
defective. The  females from  this cross and  the  reciprocal hybrid  (DBA/2  ×  CBA/N)  are 
heterozygous for the defective gene and are phenotypically normal. The male offspring of this 
latter cross, i.e. (DBA/2  ×  CBA/N) derive their X-chromosome from the DBA/2 mothers and 
hence  are normal.  DBA/1J,  SWR/J,  CE/J,  AKR/J,  C57BL/6J,  RF/J,  B10.D2/nSn,  A/J 
strains of mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. 
Cell Culture.  Spleen cells were cultured by the method of Mishell and Dutton (14) with the 
modifications as described previously (15).  Single cell suspensions of mouse spleen cells were 
cultured in 96 well flat bottom microtiter plates (Linbro FB-96 TC,  Linbro Scientific Co., 
Hamden, Conn.;  or 3596,  Costar, Cambridge, Mass.).  1 million cells were cultured in 0.2 ml 
medium under stationary conditions in a  humidified 5% COz, 95% air atmosphere at 37°C. 
The  test or control antisera were present at  1%  final concentration throughout  the culture 
period. 
Antigens.  TNP-Ficoll and TNP-dextran were prepared as described by Inman  (16)  from 
aminoethylcarbamyimethyl  derivatives of Ficoll and dextran T-500, respectively. Ficoll (average 
tool wt - 400,000 daltons) and dextran T-500 were obtained from Pharmacia Fine Chemicals, 
Piscataway, N. J. TNP-Ficoll had 83 aminoethylcarbamylmethyl groups and 56 TNP groups 
per  mole of Ficoll. TNP-BA  was  prepared  by  the  method  of Mond  et  al.  (3).  The  stock 
suspension used as starting material had 10  s microorganisms per milliliter. The concentrations 
of this antigen expressed in this paper are dilutions of the stock. TNP-lipopolysaccharide from 
Escherichia coli 0111:B4  (TNP-LPS)  was prepared according to  the  method of Jacobs  and 
Morrison  (17).  Phosphorylcholine was coupled to  B.  abortus by a  method  analogous to that 
described by Chesebro and Metzger (18). 
Plaque-Forming Cell  (PFC) Assay.  The  cultures were  assayed on  day 4  unless mentioned 
otherwise. The number of direct PFC was assayed by using a  glass slide modification of the 
hemolytic plaque assay of Jerne and Nordin (19).  Sheep erythrocytes, coupled with TNP by 
the  method  of Rittenberg and  Pratt  (20),  were  used  as  indicator cells when  cultures were 
stimulated with antigens having TNP as hapten. In the experiments in which PC-BA was the 
stimulating antigen, sheep erythrocytes coated with pneumococcal extract (21) by the method 
of Gold and Fudenberg (22) were used as target cells. The results are expressed as the geometric 
mean PFC per 10  cultured cells ×/+  relative SE of triplicate groups. 
2 Subbarao, B., A. Ahmed, W. E. Paul, I. Scher, R. Lieberman, and D. E. Mosier. 1978. Lyb7, a B cell 
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Cell Surface Iodination, Solubilization, and Immunoprecipitation.  The procedure of Kessler (23) was 
employed. It consisted of labeling 50  X  106 spleen cells, depleted of erythrocytes by hypotonic 
lysis, with  1 #Ci of Na12SI in the presence of 1-5 I U  of lactoperoxidase (grade B, sp act 42 I 
U/mg; Calbiochem, San Diego, Calif.) and reagent grade hydrogen peroxide. The washed cells 
were solubilized with 0.5% NP-40 and centrifuged at 110,000 g for 30 min. The supernate was 
preabsorbed for 30 min with 50 #1 of 10% suspension (vol/vol) of Staphylococcus aureus Cowan I 
strain (ATCC 12598) for a lysate obtained from 25  ×  106 cells. Immunoprecipitation was done 
by the method of Cuilen and Schwartz (24). 
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-P.A GE).  The procedure of Laemli 
(25)  as modified by Cullen and Schwartz (24) was employed. Samples were reduced with 2- 
mercaptoethanoi in the presence of SDS and applied to  10% polyaerylamide gels containing 
0.1% SDS. Electrophoresis was carried out at a current of 5 mA/gel. 
Antisera.  Anti-Lyb5.1 serum was prepared according to the procedure of Ahmed et al. (13). 
Briefly, hyperimmune C57BL/6  anti DBA/2 spleen cell antiserum was extensively absorbed 
with DBA/2 thymocytes until it had no anti-H-2  d activity. The antiserum was then absorbed 
with  spleen  cells  from  B-cell defective  (CBA/N  X  DBA/2)F1  male  mice  until  it  had  no 
cytotoxicity against the same cells. At this stage the antiserum still had an ability to kill 20-25% 
of the spleen cells from (CBA/N  X  DBA/2)F1 female mice or from DBA/2 mice and usually 
had cytotoxic titers of 1:16  to  1:32.  All strains that are negative in this cytotoxicity test are 
referred to as Lyb5.1 negative strains, because it is not known if there are more than two allelic 
forms of Lyb 5. 
Control  antiserum  was  prepared by absorbing anti-Lyb5.1  serum  with spleen cells from 
DBA/2 mice until it had no cytotoxicity against the same cells. Absorptions were carried out 
by addition of the antiserum to packed spleen cells and incubation at 4°C on rotary shaker for 
1 h. All antisera were deaggregated just before use by ultracentrifugation at  130,000 g for 30 
min in an airfuge (Beckman Instruments Inc., Cedar Grove, N. J.). 
Rabbit anti-mouse K used in immunoprecipitation studies was a generous gift from Dr. Rose 
Mage  (Laboratory of Immunology; NIAID, NIH). C3H/HeJ  anti-CBA/J and CBA/J anti- 
C3H/HeJ  sera were kindly provided by Dr. D.  H.  Sachs (Immunology Branch, NCI, NIH). 
These sera had cytotoxic titers of at least 1:64. 
Cytotoxic Assay.  2.5  ×  105 spleen cells depleted of erythrocytes were incubated with 50 #1 of 
antiserum diluted in 50 #1 of RPMI-1640  +  5% fetal calf serum in a microtiter plate at 4°C. 
After 1 h the plate was centrifuged at 800 g for 10 min and the supernate was discarded. Cells 
were incubated with  100 #1 of a  1:10 dilution of rabbit complement at 37°C for 30 min. The 
rabbit serum used as complement source had been screened for low background killing. The 
viability of the cells was tested by their ability to exclude trypan blue. 
Results 
Effect of Anti-Lyb 5.1 Serum on In  Vitro PFC Responses.  Spleen cells from immunolog- 
ically normal  (DBA/2  ×  CBA/N)F1 male mice were cultured with TNP-BA  (10  -2 
dilution  of stock)  or TNP-Fieoll  (10 -3 ~g/ml)  in  the  continuous  presence  of a  1% 
concentration  of anti-Lyb 5.1  or control serum.  No external source of complement 
was  added.  4  d  later  the  number  of  direct  anti-TNP  PFC  were  determined.  A 
representative experiment  of this  type  is shown  in  Table  I.  The  PFC  responses  to 
TNP-Ficoll were inhibited by more than 80% while there was little or no effect on the 
PFC response to this concentration of TNP-BA. 
Specificity  of the  Inhibition  of Responses  to  TNP-Ficoll  by  Anti-Lyb  5.1  Serum.  If the 
inhibition of PFC  responses  to TNP-Ficoll is a  specific effect  due  to  alloantibodies 
present in this antiserum, then  inhibition should be observed only with those strains 
that  have been  typed as Lyb 5.1  positive by the cytotoxicity test but should  not be 
observed with  those  strains  that  do  not  carry the  Lyb  5.1  allele.  In  20  individual 
experiments,  responses of DBA/2  (Lyb  5.1 +)  cells to TNP-Ficoll were  inhibited by 
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TABLE  I 
Inhibition of PFC Responses to TNP-Ficoll by Anti-Lyb 5.1 Serum 
Control serum*  Anti-Lyb 5.1  Inhibition 
PFC/10  6 Cells 
TNP-BA§  410~  354 
( I. 14)  (1.48) 
% 
14 
TNP-Ficoll  192  30  84 
(1.05)  (1.02) 
* (DBA/2  ×  CBA/N)Fx male spleen  cells were  cultured with the antigens in the 
presence  of a  1% concentration of control serum (Materials and Methods)  or anti- 
Lyb 5.1. 
:~ Background  PFCs which  were  <20  are subtracted.  The values  are expressed  as 
geometric means (×/+ relative SE). 
§ TNP-BA was used  at a  1:200 dilution of the stock concentration. TNP-Ficoll was 
used at  I0  -n #g/ml. 
TABLE  II 
Strain Specificity of lnhibition of PFC Responses to TNP-Fi¢oll by Anti-Lyb 5.1 
Serum 
Strain 
Percent inhibition of PFC response to* 
TNP-Ficoll  TNP-BA 
DBA/2  62  ±  4  2 +  8 
(20)  (19) 
C57BL/6  14 ±  6  -14 ±  10 
(8)  (8) 
Lyb 5.1-Positive strains:]:  63  ±  3  -1  +  7 
(40)  (41) 
Lyb 5.1-Negative  strains{}  8 ±  4  -16 ±  8 
(14)  (11) 
(CBA/N ×  DBA/2)F1  Femalel]  74 ±  5  3 ±  16 
(7)  (6) 
* Results are expressed as Mean ±  SE. The numbers within the parentheses  indicate 
the number of observations.  Negative numbers signify enhancement. 
~: DBA/2, DBA/1, CE/J, (CBA/N ×  DBA/2)F1 female, (DBA/2 ×  CBA/N)Fa male, 
C3H/HeJ. 
§ BALB/c, C57BL/6, CBA/J, SJL, A/J, AKR/J, B10.D2, RF/J. 
II Because  CBA/J and  CBA/CaJ mice are  negative in  both  the  cytotoxicity and 
blocking tests, the (CBA/N ×  DBA/2)F1  female mice are very likely to be hetero- 
zygous for the alloantigens recognized by anti-Lyb 5.1 serum. 
cantly  inhibited  (Table II).  Responses  to TNP-BA  were not blocked  in either strain. 
Summary  data  from  experiments  with  several  other  Lyb  5.1-positive  and  negative 
strains are included in Table II. These data demonstrate that  the responses of Lyb 5.1 
negative strains  to TNP-Ficoll were not affected by this antiserum.  Furthermore,  the 
responses  to TNP-Ficoll by Lyb  5.1  positive-strains  listed in Table  II were inhibited 
to approximately  the same degree as the response of DBA/2  mice. This includes mice 
which are heterozygous for Lyb 5.1. 
As an additional  control  for the significance of the blocking effect, we have tested 
another  B-cell alloantiserum,  anti-LyM  1 (CBA/J  anti-C3H/HeJ)  serum  (26)  in our B.  SUBBARAO  ET  AL. 
TABLE III 
Effect of CBA/J Anti-C3H/HeJ  Serum on PFC Responses of C3H/HeJ 
Mice 
TNP-BA  TNP-Ficoll 
PFC/10  6 cells 
Control serum  402  222 
(C3H Anti-CBA/J)  (1.06)  (1.25) 
CBA/J Anti-  560  264 
C3H/HeJ serum  (1.21)  (1.21) 
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TABLE IV 
Strain Distribution  for the Cytotoxic and Blocking Activities of Anti-Lyb 5.1 
Serum 
Inhibition of PFC re- 
Strain  Cytotoxicity  sponses  to TNP-Ficoll 
DBA/2  +  + 
DBA/I  +  + 
CE/J  +  + 
C3H/HeJ  +  + 
SWR/J  +  N.D. 
C57BL/6  -  - 
BI0.D2  -  - 
CBA/J  -  - 
BALB/c  -  - 
AKR/J  -  - 
SJL/J  -  - 
RF/J  -  - 
A/J  -  - 
CBA/CaJ  -  - 
AL/N  +  - 
system and found that this serum had no inhibitory effect on the responses to either 
TNP-Ficoll or TNP-BA (Table III). This suggests that the inhibition caused by anti- 
Lyb  5  is  not  a  simple consequence of the  binding of antibody to  any membrane 
antigen of B lymphocytes. 
A  detailed strain distribution of the cytotoxic and blocking activities of anti-Lyb 
5.1  serum  is  presented  in  Table  IV.  The  failure of anti-Lyb 5.1  serum  to  block 
responses of AL/N lymphocytes despite its capacity to lyse these cells provides initial 
evidence that  the blocking antibodies and the cytotoxic antibodies may be directed 
against  distinct alloantigens. This will be  discussed  in  more  detail  later  and  in a 
subsequent paperfl For clarity, we will refer to the ability of anti-Lyb 5.1  serum to 
selectively inhibit responses to TNP-Ficoll as its blocking activity. 
Susceptibility of PFC Responses to  Various TI-1 and TI-2 Antigens to Inhibition by Anti-Lyb 
5.1  Serum.  We  observed  that  the  extent  of inhibition by  anti-Lyb 5  serum  was 
approximately the same, over a  wide range of concentrations (10-2-10  -5 #g/ml) of 
TNP-Fieoll (Fig. 1). Similarly, this antiserum inhibited the PFC responses to another 
TI-2 antigen, TNP-dextran, at all antigen concentrations tested (Fig. 2). In contrast, 
the effect of anti-Lyb 5.1 serum on PFC responses to TNP-BA was dependent on the 
concentration of  the  antigen  used  (Table  V).  At  the  concentration of  TNP-BA 500  ACTIVATION OF  B  LYMPHOCYTES  BY  THYMUS-INDEPENDENT ANTIGENS 
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Fzo.  1.  Effect of anti-Lyb 5.1 serum on PFC responses to different concentrations of TNP-Ficoll. 
Control serum is an anti-Lyb 5.1 serum that has been absorbed with spleen cells from DBA/2 mice 
until it has  neither cytotoxic nor blocking activity.  The antisera were used  at  1% concentration. 
DBA/I spleen cells were cultured in Mishell-Dutton cultures in the presence  of indicated antigen 
concentrations and control serum (0) or anti-Lyb 5.1 (C)) serum. 
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FIo.  2.  Effect of anti-Lyb 5.1 serum on in vitro primary responses to TNP-dextran. DBA/2 spleen 
cells were cultured in presence of control serum (0) or anti-Lyb 5.1 (O) serum. Other conditions are 
the same as described  in legend to Fig.  1. 
employed in the experiments  thus  far described  (10 -2 dilution of the stock), anti-Lyb 
5.1  caused  no  significant  inhibition  of the  anti-TNP  response.  However,  at  lower 
concentrations  of TNP-BA  (10 -4 or lower)  the responses are substantially  diminished 
in presence of anti-Lyb  5.1  serum.  It is interesting to note that  CBA/N  mice respond 
poorly to such low doses of TNP-BA  (3). 
Anti-Lyb  5.1  serum  does not  affect  the PFC  responses  to TNP-LPS,  another TI-1 
antigen,  at  all  the  concentrations  of the  antigen  tested  (1-100  /~g/ml).  However, 
responses  to a  wide  dose  range  of PC-BA  are suppressed  by  anti-Lyb  5.1  antiserum 
(Table VI).  PC-BA belongs to the TI-2 class of antigens since the mice with CBA/N B.  SUBBARAO  ET  AL.  501 
TABLE  g 
Effect of Anti-Lyb  5.1 Serum on PFC Responses to Different Concentrations of TNP- 
B. abortus 
Anti-TNP PFC/106 cells in pres- 
ence of: 
Concentra-  Inhibition  Mean percent in- 
tion*  hibition ±  SE:~ 
Control serum  Anti-Lyb 5.1 se- 
rum 
% 
1:102  508  526  -4  15 4-  17 
(1.01)  (1.07) 
1:104  308  86  72  67 ±  10 
(1.11)  (1.18) 
hi0  s  166  24  84  64 ±  24 
(1.19)  (1.84) 
* Concentrations are expressed as dilutions of the stock, which has lO  s micro-organisms 
per ml. 
:~ The values are average results from three experiments. 
TABLE  VI 
Effect of Anti-Lyb  5.1 Serum on Antibody Responses to TI-I and TI-2 Ant;gens 
Ability of  Inhibition by anti-Lyb  Class of the an-  Antigen*  CBA/N mice 
to respond  5. I:~  tigen 
% 
TNP-BA  +  -1  ±  7  (41)  TI-1 
TNP-LPS  +  11  ±  10 (2)  TI-1 
TNP-Ficoll  -  63 ±  3  (40)  TI-2 
TNP-Dextran  -  68 4- 9  (3)  TI-2 
PC-BA  -  71  ±  5  (7)  TI-2 
* TNP-BA and PC-BA were used at  1:200 and 1:1,000 dilution of the stock, respec- 
s  tively. The stock solutions of TNP-BA and PC-BA, respectively,  contained 10  and 
5  X  l0  s micro-organisms per ml. 
Concentrations of TNP-LPS, TNP-Ficoll, and TNP-dextran in that order are  10 
#g/ml,  10  -s  #g/ml,  and  10-4 #g/ml.  PFC  responses  were  measured  4  d  after 
initiation of the cultures and they varied from 80 to 400 PFC per 1 million cultured 
cells. 
:l: The values represent mean  ±  SE with the number of experiments given in the 
parentheses. 
immune  defect do not respond to phosphorylcholine  on any carrier including BA (27). 
Thus,  the responses to the three TI-2 antigens tested are susceptible to inhibition by 
anti-Lyb  5.1 serum. Responses to optimal  concentrations  of two TI- 1 antigens are not 
inhibited,  although  anti-Lyb  5.1  serum  does diminish  the response  to a  low concen- 
tration of TNP-BA. 
Timing of Addition of Anti-Lyb  5.1 Serum  to the Cell Cultures.  As a  preliminary  step in 
the analysis of the mechanism  by which anti-Lyb  5.1 serum inhibited B  cell responses, 
we wished to know when  the antiserum  had  to be added  to obtain  inhibition. To test 
this we added  anti-Lyb  5.1  or control serum to the culture at different times after the 
addition  of TNP-FicoI1.  Results of one such experiment  are presented  in Fig.  3. Anti- 
Lyb  5.1  caused  significant  inhibition  when  added  as  late  as  14  h  after  initiation of 
culture;  when  added  at  later times,  little or no inhibition  was  observed.  The  loss of 
susceptibility to inhibition may be due either to a  loss of the Lyb 5.1 antigen from the 502  ACTIVATION  OF  B  LYMPHOCYTES  BY  THYMUS-INDEPENDENT  ANTIGENS 
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FIG.  3.  DBA/I spleen cells were cultured in presence of 10  -~ p,g/ml concentration of TNP-FicoI1. 
Control serum and anti-Lyb 5.1  serum were added to parallel cultures at the indicated times after 
initiation  of the cultures.  PFC  responses were  assayed 4  d  later.  In  this experiment response in 
presence of control serum was 252 PFC/106 cells and it was taken as 100%. 
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FIG.  4.  SDS-polyacrylamide gel electrophoresis of 12~I labeled (DBA/2  ×  CBA/N-)F1 male spleen 
cell membrane proteins precipitated by rabbit anti-mouse light-chain serum (A)  and by anti-Lyb 
5. l serum (B). Precipitates were reduced by boiling in 5% 2-mercaptoethanol and 2% SDS and were 
subjected to electrophoresis in  10% polyacrylamide gels with 0.1% SDS. 2-mm slices were cut and 
the radioactivity was measured. 
cell surface or because the Lyb 5.1  determinants have no further role in the events 
that lead to maturation of B cells to PFC. 
Nature of Cell Surface Molecules Recognized by Anti-Lyb  5.1 Serum.  It has been shown 
previously that  an  alloanti-~ serum also can  inhibit  in  vitro antibody responses  to 
TNP-Ficoll (28).  Spleen cells from CBA/N or (CBA/N  ×  DBA/2)F1 male mice have 
an sIgD to sIgM ratio which is approximately ~/s that of spleen cells from normal mice 
(9).  Furthermore,  Lyb  5-negative  cells  from  normal  adult  mice  have a  surface  Ig 
phenotype similar to that of CBA/N cells, i.e, sIgM >  sIgD (13).  Hence it is a formal 
possibility  that  C57BL/6  anti-DBA/2  serum  contains  anti-8  antibody  and  that 
absorption with  (CBA/N  ×  DBA/2)Fa male spleen cells which may be low in sIgD 
density could have failed to completely remove anti-8 activity. To test this possibility, 
cells  were  surface  labeled  with  125I and  the  solubilized  membrane  proteins  were 
subjected to immunoprecipitation with anti-Lyb 5.1 serum and S. aureus. The resultant 
precipitates were dissolved in 2% SDS and were analyzed on SDS-PAGE as described. 
Fig. 4 B shows the result of such an experiment. For comparison, SDS-PAGE pattern 
of an immunoprecipitate obtained with rabbit anti-mouse-•  is presented in Fig. 4 A. B.  SUBBARAO  ET  AL.  503 
It is clear that there are no molecules in the material reactive with anti-Lyb 5.1 that 
migrate in the position of/,t (1.8 cm), 8  (2.5  cm), or 7  (3.9 cm)  heavy chains.  The 
pattern obtained with anti-Lyb 5.1 is complex and it is difficult to conclude which of 
the  peaks  represents the  Lyb 5.1  molecules. This result  L  not  surprising  since our 
results suggest that at least two antibodies are present in anti-Lyb 5.1 serum, each of 
which is directed against a different cell surface antigenfl 
Discussion 
In  this  paper we  have demonstrated  that  anti-Lyb 5.1,  an  alloantiserum  which 
recognizes a mature subset of B lymphocytes, selectively inhibits in vitro PFC responses 
to  TI-2  antigens,  but  does  not  effect responses  to  optimal  concentrations of TI-1 
antigens. This selective inhibition was seen in four Lyb 5.1-positive strains (DBA/2, 
DBA/1, C3H/HeJ and CE/J). None of the Lyb 5.1-negative strains gave responses to 
TNP-Ficoll that  were susceptible  to  inhibition  by the  presence of anti-Lyb 5.1  se- 
rum during the culture period. However, there is one strain, AL/N, in which responses 
to TNP-Ficoll are not affected by anti-Lyb 5.1  serum even though AL/N mice are 
positive for Lyb 5.1  expression by the cytotoxicity test. This finding suggested that 
the  inhibitory and  cytotoxic activities of anti-Lyb 5.1  serum  might  be due to two 
different specificities present in one antiserum. In a subsequent paper  2 we show that 
these two activities (blocking and cytotoxicity) segregate independently in the mice 
from  the  backcross  (C57BL/6  ×  DBA/2)  ×  C57BL/6.  Thus  the  cytotoxic and 
blocking activities of this alloantiserum are due to recognition of two different cell 
surface determinants which are encoded by unlinked genes. 
For  the  sake  of clarity  in  this  discussion,  we  will  refer  to  the  specific  antigen 
recognized by the blocking activity of this antiserum as Lyb 7.1 as opposed to Lyb 5.1 
which  was  defined  by  the  cytotoxic  activity  of the  antiserum.  In  the  following 
discussion, any reference to anti-Lyb 7.1 is only to this blocking activity present in the 
antioLyb 5.1 serum since all the experiments reported in this paper make use of anti- 
Lyb  5.1  serum.  Anti-Lyb  7.1  activity  is  present  in  an  antiserum  that  has  been 
extensively absorbed with spleen cells from the  (CBA/N  X  DBA/2)F1 male  mice, 
strongly suggesting that Lyb 7.1 is also present only on a subset of B lymphocytes that 
are absent  from mice with  the  CBA/N  defect.  Since there are no  Lyb 5  + cells in 
CBA/N  mice, it  is likely that  Lyb 7 is present  exclusively on Lyb 5  + B  cells.  The 
designation Lyb 7.1  is a  preliminary one until decisive studies on tissue distribution 
are completed. 
In vitro response to TI-2 antigens are always significantly suppressed by anti-Lyb 
7.1,  but  the  inhibition  was  never  total,  the  average  inhibition  being  62%.  It  is 
conceivable that this reflects a low titer of the antibody, especially since the inhibition 
falls off rapidly at greater dilution  (data not shown).  However, since similar results 
were obtained with many different batches of the antiserum, it is formally possible 
that  there is  further heterogeneity among the B  lymphocytes that  respond to TI-2 
antigens. At present we are making efforts to produce these antibodies in higher titers 
by alternative approaches. 
Although the anti-TNP antibody response to optimal concentrations of TNP-BA is 
not suppressed by anti-Lyb 7.1 antibodies, there is significant inhibition of responses 
to lower concentrations of this antigen. As mentioned above, mice with the CBA/N 
defect respond poorly to such low doses of TNP-BA while giving normal responses to 
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concentrations of TNP-BA stimulate only Lyb 7  + cells and the responses of such cells 
are inhibited by anti-Lyb 7.1 serum. It is likely that both Lyb 7  + and Lyb 7- cells are 
involved  in  responses  to  high  doses  of TNP-BA  and  the  failure  to  observe  any 
inhibition  at these concentrations may be the result of a  relative insensitivity of the 
present  culture  system  to  changes  in  precursor  frequency.  One  prediction  of this 
hypothesis is that  anti-Lyb  7.1  activity will  inhibit  responses of Lyb 7  + cells to any 
antigen.  An  alternative  possibility is  that  Lyb  7  + cells are involved in  responses of 
adult mice to TNP-BA at both high and low doses but that only the responses to low 
concentrations are susceptible to inhibition by anti-Lyb 7.1. This issue can be resolved 
by an analysis of the effect of anti-Lyb  7.1  serum on both precursor frequency and 
burst size in responses to high and low concentrations of TI-1 antigens. 
Our  experiments  do  not  address  directly  the  question  of the  mechanism  of the 
inhibition  of  responses  to  TI-2  antigens  by  anti-Lyb  7.1  antibodies.  Since  two 
alloantisera that have been tested, namely anti-8 (28)  and anti-Lyb 7.1,  both inhibit 
the responses to TNP-Ficoll, it is conceivable that a perturbation of the cell membrane 
due to interaction  of any antiserum with a  cell surface component may inhibit  the 
response of B cells to this class of antigens.  The inability of CBA/J anti-C3H/HeJ 
serum, which is cytotoxic for B cells (26), to cause any inhibition of the responses to 
TNP-Ficoll  constitutes  strong evidence against  this  possibility.  Similarly as will  be 
shown subsequently, 2 anti-Lyb 5.1  serum fails to inhibit responses to Lyb 5.1 +, Lyb 
7.1- backcross mice. 
Another  explanation  of the  inhibition  is  that  binding  of anti-Lyb  7.1  to  Lyb  7 
molecules on  the  cell  surface stericaliy  inhibits  any effective interaction  of antigen 
with the sIg receptors or some mitogen receptors  (29).  Since the responses of spleen 
cells from an animal homozygous or heterozygous for Lyb 7 are equally sensitive to 
inhibition, 2 such a mechanism for anti-Lyb 7.1  action seems unlikely. This argument 
presumes that in the heterozygous mice, half of the Lyb 7 molecules remain unoccu- 
pied  by  the  antibodies  directed  against  the  Lyb  7.1  determinant  and  that  these 
molecules could be sufficient for the activation of the B lymphocytes. The equivalent 
susceptibility of homozygous and heterozygous cells seems more consistent with the 
concept  that  interaction  of anti-Lyb  7.1  antibodies  with  Lyb  7.1  molecules  may 
deliver an off signal to the cell and thus lead to inhibition of responses of Lyb 7  + B 
cells. Indeed, Lyb 7 may be a site through which suppression is mediated in vivo and 
inhibition by anti-Lyb 7.1  may be analogous to a physiological process. 
It is interesting to note that an alloanti-8 serum also selectively inhibits responses to 
TI-2 antigens  (28).  The characteristics of inhibition  by anti-Lyb  7.1  and  anti-8 are 
similar but  the  action  of anti-Lyb  7.1  is  not  due  to  its contamination  with  anti-8 
antibody. This is shown both by analysis of membrane proteins precipitated by anti- 
Lyb 7.1  and by genetic studies which show a  segregation of genes for Lyb 7 and 8. 2 
Finally, anti-Lyb 3, which is similar to anti-Lyb 5 to the extent that it defines an 
antigen present only on a subset of B lymphocytes, also has some functional properties 
(30). This antiserum has been shown to substitute for T  cell help in vivo under certain 
conditions.  Although  anti-Lyb  5  serum  could  contain  anti-Lyb  3-like  activity,  no 
functional  evidence of such  activity  was  seen  in  the  present  in  vitro experiments. 
However,  it  is  formally possible that  the  activation  effects of anti-Lyb  3  and  the 
blocking  effects  of anti-Lyb  7  simply  reflect  different  consequences  of the  same 
interaction, dictated by the precise conditions in which they occur. B.  SUBBARAO ET AL.  505 
Summary 
Lyb 5 is a  B-cell alloantigen which is expressed on 50-60% of B cells. It was defined 
originally on the basis of cytotoxicity. We have described a new reactivity within the 
anti-Lyb 5 serum on the basis of selective inhibition of antibody responses in vitro by 
this antiserum in the absence of complement. This inhibitory activity of anti-Lyb 5.1 
serum appears to be due to recognition of antigenic determinants  different from the 
prototype antigens detected in the cytotoxicity assay. 
Anti-Lyb 5 serum incorporated into spleen cell cultures selectively inhibits antibody 
responses  to a  class of thymus-independent  antigens  CFI-2) previously characterized 
by their  failure  to  elicit  antibody  formation  in  immature  mice or in  the  defective 
CBA/N  strain.  Responses  to  optimal  concentrations  of TI-1  antigens,  which  can 
induce antibody synthesis in these mice, are unaffected by the addition  of anti-Lyb 
5.1  serum.  The  B-cell  alloantigen  defined  by  this  functional  assay  is  designated 
tentatively  Lyb 7 and  it  is shown to be distinct  from cell surface immunoglobulins. 
Lyb 7 appears to have a  role in the activation of B lymphocytes by the TI-2 class of 
thymus-independent  antigens. 
Received  for publication 18 October 1978. 
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